Table 2.
Change in the most commonly used prescription drugs in the last year before death (N = 1603)
| Percentage of patients receiving drug | |||
|---|---|---|---|
| 12th month | 6th month | Final month | |
| Psycholeptics | 32.8 | 39.2 | 57.4 |
| Antipsychotics | 2.7 | 3.4 | 4.9 |
| Anxiolytics | 15.7 | 20.7 | 38.2 |
| Hypnotics and sedatives | 23.8 | 27.9 | 39.2 |
| Analgesics | 26.0 | 32.9 | 47.2 |
| Opioids | 11.6 | 15.9 | 31.1 |
| Other analgesics and antipyretics | 21.0 | 25.9 | 33.9 |
| Drugs for constipation | 21.3 | 32.3 | 46.5 |
| Other nervous system drugs | 26.9 | 38.3 | 45.2 |
| Riluzole | 26.7 | 37.9 | 45.0 |
| Psychoanaleptics | 28.4 | 37.0 | 44.1 |
| Antidepressants | 26.4 | 34.3 | 42.4 |
| Anti-dementia drugs | 3.2 | 3.9 | 3.4 |
| Antithrombotic agents | 37.1 | 38.2 | 36.9 |
| Vitamin K antagonists | 4.9 | 5.0 | 4.6 |
| Heparin group | 1.2 | 1.2 | 2.9 |
| Aspirin | 30.6 | 31.0 | 29.4 |
| Cough and cold preparations | 17.3 | 24.3 | 31.9 |
| Beta-blocking agents | 26.5 | 27.3 | 27.3 |
| Diuretics | 24.0 | 24.7 | 25.2 |
| High-ceiling diuretics | 13.1 | 15.0 | 17.8 |
| Drugs for acid-related disorders | 16.8 | 18.6 | 24.5 |
| Agents acting on the renin-angiotensin system | 25.2 | 23.8 | 22.1 |
| Antianemic preparations | 17.5 | 19.3 | 20.0 |
| Emollients and protectives | 12.7 | 15.1 | 17.7 |
| Ophthalmologicals | 12.6 | 13.8 | 15.6 |
| Drugs for obstructive airway diseases | 10.7 | 12.1 | 15.3 |
| Drugs for functional gastrointestinal disorders | 4.4 | 6.7 | 14.9 |
| Antibacterials for systemic use | 9.5 | 9.5 | 14.2 |
| Calcium channel blockers | 16.1 | 14.6 | 12.7 |
| Mineral supplements | 11.7 | 12.1 | 11.3 |
| Calcium | 9.1 | 9.1 | 7.5 |
| Potassium | 2.9 | 3.3 | 3.8 |
| Antiemetics and antinauseants | 3.5 | 5.7 | 10.9 |
| Lipid-modifying agents (including statins) | 18.2 | 15.1 | 10.8 |